Presbia Plc Ord Shs (LENS) 4.19 $LENS Presbia t
Post# of 273254
Posted On: 09/20/2016 9:05:06 AM
Presbia Plc Ord Shs (LENS) 4.19 $LENS
Presbia to Participate in the 2016 Aegis Capital Growth Conference
BusinessWire - 1 hr 4 mins ago
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens(TM), a propriety optical lens implant for treating the age-related loss of near-vision, announced that Jarett Fenton, Chief Financial Officer of Presbia is scheduled to present at the AEGIS Growth Conference being held September 20th through 22th at the Encore at Wynn Las Vegas. Mr. Fenton will be available for one-on-one meetings at the conference.
LENS: 4.19 (+0.22)
Presbia to Participate in the XXXIV Congress of the European Society of Cataract & Refractive Surgeons and in the International Society of Presbyopia 2016
BusinessWire - Thu Sep 08, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration will participate in the XXXIV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), Europe's leading organization for cataract and refractive surgeons in Copenhagen on September 10th through 14th.
LENS: 4.19 (+0.22)
Presbia to Participate in the Rodman & Renshaw 18th Annual Healthcare Conference
BusinessWire - Wed Sep 07, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens(TM), a propriety optical lens implant for treating the age-related loss of near-vision, announced that Jarett Fenton, CFO of Presbia, is scheduled to present at the Rodman & Renshaw 18th Annual Healthcare Conference being held September 11th through 13th at the Lotte New York Palace Hotel in New York City. Mr. Fenton will be available for one-on-one meetings at the conference.
LENS: 4.19 (+0.22)
Presbia to Participate in the 2016 Baird Global Health Conference
BusinessWire - Thu Sep 01, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens(TM), a propriety optical lens implant for treating the age-related loss of near-vision, announced that Todd Cooper, President and CEO of Presbia, is scheduled to present at the Baird Annual Global Healthcare Conference being held the 7th and 8th of September at the Lotte New York Palace Hotel in New York City.
LENS: 4.19 (+0.22)
Presbia Acquires Comprehensive Patent Portfolio for the Presbia Flexivue Microlens(TM)
BusinessWire - Mon Aug 22, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that on August 2, 2016, its wholly-owned subsidiary, Presbia Ireland, Ltd., completed the purchase of the assets of Neoptics AG ("Neoptics"
, including its intellectual property portfolio.
LENS: 4.19 (+0.22)
Outcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent Results
BusinessWire - Thu Aug 11, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced the 12-month results of the 14 Presbia Flexivue Microlens(TM) surgeries performed on South Korean patients by Dr. Lee Jong Ho, founder of the BalGeunSeSang (BGSS) Eye Clinic, one of the world's most prestigious eye clinics. The results of the surgeries using the Presbia Flexivue Microlens, an optical lens implant and an innovative solution for treating the age-related loss of near-vision, were presented at a recent symposium held in Seoul, South Korea.
LENS: 4.19 (+0.22)
Presbia to Participate in JMP Securities Life Science Conference 2016 in New York
BusinessWire - Thu Jun 09, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that Todd Cooper, President and CEO, is scheduled to present at the JMP Securities Life Sciences Conference 2016 on Tuesday, June 21 at 3:00 p.m. ET. The Conference is being held June 21 and 22, 2016 at The St. Regis New York.
LENS: 4.19 (+0.22)
Presbia to Participate in 29th International Congress of German Ophthalmic Surgeons
BusinessWire - Wed Jun 08, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens(TM), a proprietary optical lens implant for treating presbyopia, announced that it will be participating in the 29th International Congress of German Ophthalmic Surgeons (DOC). The Congress is being held June 9th to 11th, 2016 in Nuremburg at Nurnberg Convention Center, NCC Ost.
LENS: 4.19 (+0.22)
Top U.S. LASIK Surgeon Supports Presbia's Microlens as Solution to Near-Vision
BusinessWire - Thu Jun 02, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that top U.S. LASIK surgeon Dr. Kerry Assil strongly supports the Presbia Flexivue Microlens(TM) as an excellent treatment for presbyopia, the loss of near-vision. The Presbia Flexivue Microlens is an innovative solution for presbyopia, which substitutes a proprietary optical lens implant for the requirement to wear reading glasses. Dr. Assil spoke with Jefferies, the global investment banking firm on a May 10, 2016 investor call discussing the broad topic of presbyopia-treating technologies and corneal inlay technologies.
LENS: 4.19 (+0.22)
All Patients in Presbia Flexivue Microlens(TM) FDA Study Complete 6-Month Post-Operative Visits
BusinessWire - Tue May 31, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that all 421 subjects treated with the Presbia Flexivue Microlens(TM) as part of its U.S. Food and Drug Administration (FDA) pivotal study completed their 6-month post-operative visits, one step closer to making the submission of its final PMA module to the FDA in approximately 18 months. The Presbia Flexivue Microlens is a revolutionary optical lens implant for treating presbyopia, the age-related loss of near-vision.
LENS: 4.19 (+0.22)
Presbia to Participate in Jefferies 2016 Global Healthcare Conference
BusinessWire - Mon May 23, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens(TM), a proprietary optical lens implant for treating presbyopia, announced today that Todd Cooper, President and CEO, is scheduled to present at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016 at 10:00 a.m. ET. The Conference is being held from June 7 to 10, 2016 in New York, NY at the Grand Hyatt. Mr. Cooper will be available for one-on-one meetings at the Conference.
LENS: 4.19 (+0.22)
Presbia PLC elects Gerald Farrell, PhD to the board
M2 - Thu Jan 21, 4:51AM CST
Ophthalmic company Presbia PLC (NasdaqGM:LENS) disclosed on Wednesday the addition of Gerald Farrell, PhD to its board of directors and as a member of its audit committee.
LENS: 4.19 (+0.22)
Presbia PLC Appoints Gerald Farrell, Ph.D. to the Board of Directors
BusinessWire - Wed Jan 20, 3:30PM CST
The Board of Directors of Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that it has appointed Gerald Farrell, Ph.D. to serve on its Board of Directors and as a member of its Audit Committee.
LENS: 4.19 (+0.22)
Presbia to Hold 2015 Year-End Investor Conference Call
BusinessWire - Thu Dec 03, 6:30PM CST
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration announced that it will hold a 2015 year-end investor conference call on Thursday, December 17, 2015, at 4:30 p.m. Eastern Time. President and CEO Todd Cooper will host the conference call along with Randy Thurman, Executive Chairman of the Board. Interested parties can listen to the call via the following:
LENS: 4.19 (+0.22)
Can The Uptrend Continue for Presbia (LENS)?
Zacks Equity Research - Zacks Investment Research - Fri Nov 27, 7:06AM CST
Investors certainly have to be happy with Presbia PLC (LENS) and its short term performance
LENS: 4.19 (+0.22)
Presbia to Participate in 27th Annual Piper Jaffray Healthcare Conference
BusinessWire - Thu Nov 12, 7:00AM CST
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration announced that Todd Cooper, President and CEO is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2015 at 12:10 p.m. Eastern Time at The New York Palace located at 455 Madison Avenue. The Presbia Flexivue Microlens(TM) is an innovative solution to treat presbyopia, the age-related loss of near-vision.
LENS: 4.19 (+0.22)
Presbia Introduces Time-Saving Disposable Microlens Inserter
BusinessWire - Mon Oct 05, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company introduced its new, innovative disposable inserter for the Presbia Flexivue Microlens(TM) at the Australasian Society of Cataract and Refractive Surgeons (AUSCRS) conference held from October 7th through the 10th in Noosa, Queensland, Australia. The Presbia Flexivue Microlens is a proprietary optical lens implant for treating presbyopia, the age-related loss of near-vision. With its simplified action, the new inserter further reduces the time required to complete the Presbia Flexivue Microlens procedure, allowing surgeons to safely complete more procedures per hour of surgery time.
LENS: 4.19 (+0.22)
Presbia to Participate in the 2015 Australasian Society of Cataract and Refractive Surgeons Conference
BusinessWire - Thu Sep 24, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration will be attending the 19th Annual Australasian Society of Cataract and Refractive Surgeons (AUSCRS) Conference being held from October 7th through the 10th at Outrigger Conference Centre in Noosa, Queensland, Australia. Presbia representatives, including President and CEO Todd Cooper and Vice President of Sales John Strobel, will be at the meeting to discuss the Presbia Flexivue Microlens(TM) with AUSCRS members, leaders in the field of ophthalmology. The Presbia Flexivue Microlens is a corneal inlay solution for presbyopia, the age-related loss of near-vision.
LENS: 4.19 (+0.22)
Presbia Flexivue Microlens(TM) Implanted in More Than 1,000 Patients Worldwide
BusinessWire - Thu Sep 17, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic medical device company and leader in near-vision restoration announced today that more than 1000 patients worldwide have been treated with the Presbia Flexivue Microlens(TM).
LENS: 4.19 (+0.22)
Presbia Completes Second Stage Enrollment in the US FDA Pivotal Study of Presbia Flexivue Microlens(TM)
BusinessWire - Thu Sep 10, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near vision restoration announced that it has completed the second stage enrollment of its U.S. Food and Drug Administration (FDA) pivotal study, a significant milestone in the FDA approval process of its Presbia Flexivue Microlens(TM).
LENS: 4.19 (+0.22)
Presbia to Participate in the 2016 Aegis Capital Growth Conference
BusinessWire - 1 hr 4 mins ago
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens(TM), a propriety optical lens implant for treating the age-related loss of near-vision, announced that Jarett Fenton, Chief Financial Officer of Presbia is scheduled to present at the AEGIS Growth Conference being held September 20th through 22th at the Encore at Wynn Las Vegas. Mr. Fenton will be available for one-on-one meetings at the conference.
LENS: 4.19 (+0.22)
Presbia to Participate in the XXXIV Congress of the European Society of Cataract & Refractive Surgeons and in the International Society of Presbyopia 2016
BusinessWire - Thu Sep 08, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration will participate in the XXXIV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), Europe's leading organization for cataract and refractive surgeons in Copenhagen on September 10th through 14th.
LENS: 4.19 (+0.22)
Presbia to Participate in the Rodman & Renshaw 18th Annual Healthcare Conference
BusinessWire - Wed Sep 07, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens(TM), a propriety optical lens implant for treating the age-related loss of near-vision, announced that Jarett Fenton, CFO of Presbia, is scheduled to present at the Rodman & Renshaw 18th Annual Healthcare Conference being held September 11th through 13th at the Lotte New York Palace Hotel in New York City. Mr. Fenton will be available for one-on-one meetings at the conference.
LENS: 4.19 (+0.22)
Presbia to Participate in the 2016 Baird Global Health Conference
BusinessWire - Thu Sep 01, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens(TM), a propriety optical lens implant for treating the age-related loss of near-vision, announced that Todd Cooper, President and CEO of Presbia, is scheduled to present at the Baird Annual Global Healthcare Conference being held the 7th and 8th of September at the Lotte New York Palace Hotel in New York City.
LENS: 4.19 (+0.22)
Presbia Acquires Comprehensive Patent Portfolio for the Presbia Flexivue Microlens(TM)
BusinessWire - Mon Aug 22, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that on August 2, 2016, its wholly-owned subsidiary, Presbia Ireland, Ltd., completed the purchase of the assets of Neoptics AG ("Neoptics"
, including its intellectual property portfolio. LENS: 4.19 (+0.22)
Outcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent Results
BusinessWire - Thu Aug 11, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced the 12-month results of the 14 Presbia Flexivue Microlens(TM) surgeries performed on South Korean patients by Dr. Lee Jong Ho, founder of the BalGeunSeSang (BGSS) Eye Clinic, one of the world's most prestigious eye clinics. The results of the surgeries using the Presbia Flexivue Microlens, an optical lens implant and an innovative solution for treating the age-related loss of near-vision, were presented at a recent symposium held in Seoul, South Korea.
LENS: 4.19 (+0.22)
Presbia to Participate in JMP Securities Life Science Conference 2016 in New York
BusinessWire - Thu Jun 09, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that Todd Cooper, President and CEO, is scheduled to present at the JMP Securities Life Sciences Conference 2016 on Tuesday, June 21 at 3:00 p.m. ET. The Conference is being held June 21 and 22, 2016 at The St. Regis New York.
LENS: 4.19 (+0.22)
Presbia to Participate in 29th International Congress of German Ophthalmic Surgeons
BusinessWire - Wed Jun 08, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens(TM), a proprietary optical lens implant for treating presbyopia, announced that it will be participating in the 29th International Congress of German Ophthalmic Surgeons (DOC). The Congress is being held June 9th to 11th, 2016 in Nuremburg at Nurnberg Convention Center, NCC Ost.
LENS: 4.19 (+0.22)
Top U.S. LASIK Surgeon Supports Presbia's Microlens as Solution to Near-Vision
BusinessWire - Thu Jun 02, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that top U.S. LASIK surgeon Dr. Kerry Assil strongly supports the Presbia Flexivue Microlens(TM) as an excellent treatment for presbyopia, the loss of near-vision. The Presbia Flexivue Microlens is an innovative solution for presbyopia, which substitutes a proprietary optical lens implant for the requirement to wear reading glasses. Dr. Assil spoke with Jefferies, the global investment banking firm on a May 10, 2016 investor call discussing the broad topic of presbyopia-treating technologies and corneal inlay technologies.
LENS: 4.19 (+0.22)
All Patients in Presbia Flexivue Microlens(TM) FDA Study Complete 6-Month Post-Operative Visits
BusinessWire - Tue May 31, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that all 421 subjects treated with the Presbia Flexivue Microlens(TM) as part of its U.S. Food and Drug Administration (FDA) pivotal study completed their 6-month post-operative visits, one step closer to making the submission of its final PMA module to the FDA in approximately 18 months. The Presbia Flexivue Microlens is a revolutionary optical lens implant for treating presbyopia, the age-related loss of near-vision.
LENS: 4.19 (+0.22)
Presbia to Participate in Jefferies 2016 Global Healthcare Conference
BusinessWire - Mon May 23, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens(TM), a proprietary optical lens implant for treating presbyopia, announced today that Todd Cooper, President and CEO, is scheduled to present at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016 at 10:00 a.m. ET. The Conference is being held from June 7 to 10, 2016 in New York, NY at the Grand Hyatt. Mr. Cooper will be available for one-on-one meetings at the Conference.
LENS: 4.19 (+0.22)
Presbia PLC elects Gerald Farrell, PhD to the board
M2 - Thu Jan 21, 4:51AM CST
Ophthalmic company Presbia PLC (NasdaqGM:LENS) disclosed on Wednesday the addition of Gerald Farrell, PhD to its board of directors and as a member of its audit committee.
LENS: 4.19 (+0.22)
Presbia PLC Appoints Gerald Farrell, Ph.D. to the Board of Directors
BusinessWire - Wed Jan 20, 3:30PM CST
The Board of Directors of Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that it has appointed Gerald Farrell, Ph.D. to serve on its Board of Directors and as a member of its Audit Committee.
LENS: 4.19 (+0.22)
Presbia to Hold 2015 Year-End Investor Conference Call
BusinessWire - Thu Dec 03, 6:30PM CST
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration announced that it will hold a 2015 year-end investor conference call on Thursday, December 17, 2015, at 4:30 p.m. Eastern Time. President and CEO Todd Cooper will host the conference call along with Randy Thurman, Executive Chairman of the Board. Interested parties can listen to the call via the following:
LENS: 4.19 (+0.22)
Can The Uptrend Continue for Presbia (LENS)?
Zacks Equity Research - Zacks Investment Research - Fri Nov 27, 7:06AM CST
Investors certainly have to be happy with Presbia PLC (LENS) and its short term performance
LENS: 4.19 (+0.22)
Presbia to Participate in 27th Annual Piper Jaffray Healthcare Conference
BusinessWire - Thu Nov 12, 7:00AM CST
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration announced that Todd Cooper, President and CEO is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2015 at 12:10 p.m. Eastern Time at The New York Palace located at 455 Madison Avenue. The Presbia Flexivue Microlens(TM) is an innovative solution to treat presbyopia, the age-related loss of near-vision.
LENS: 4.19 (+0.22)
Presbia Introduces Time-Saving Disposable Microlens Inserter
BusinessWire - Mon Oct 05, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company introduced its new, innovative disposable inserter for the Presbia Flexivue Microlens(TM) at the Australasian Society of Cataract and Refractive Surgeons (AUSCRS) conference held from October 7th through the 10th in Noosa, Queensland, Australia. The Presbia Flexivue Microlens is a proprietary optical lens implant for treating presbyopia, the age-related loss of near-vision. With its simplified action, the new inserter further reduces the time required to complete the Presbia Flexivue Microlens procedure, allowing surgeons to safely complete more procedures per hour of surgery time.
LENS: 4.19 (+0.22)
Presbia to Participate in the 2015 Australasian Society of Cataract and Refractive Surgeons Conference
BusinessWire - Thu Sep 24, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration will be attending the 19th Annual Australasian Society of Cataract and Refractive Surgeons (AUSCRS) Conference being held from October 7th through the 10th at Outrigger Conference Centre in Noosa, Queensland, Australia. Presbia representatives, including President and CEO Todd Cooper and Vice President of Sales John Strobel, will be at the meeting to discuss the Presbia Flexivue Microlens(TM) with AUSCRS members, leaders in the field of ophthalmology. The Presbia Flexivue Microlens is a corneal inlay solution for presbyopia, the age-related loss of near-vision.
LENS: 4.19 (+0.22)
Presbia Flexivue Microlens(TM) Implanted in More Than 1,000 Patients Worldwide
BusinessWire - Thu Sep 17, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic medical device company and leader in near-vision restoration announced today that more than 1000 patients worldwide have been treated with the Presbia Flexivue Microlens(TM).
LENS: 4.19 (+0.22)
Presbia Completes Second Stage Enrollment in the US FDA Pivotal Study of Presbia Flexivue Microlens(TM)
BusinessWire - Thu Sep 10, 7:00AM CDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near vision restoration announced that it has completed the second stage enrollment of its U.S. Food and Drug Administration (FDA) pivotal study, a significant milestone in the FDA approval process of its Presbia Flexivue Microlens(TM).
LENS: 4.19 (+0.22)
(0)
(0)Scroll down for more posts ▼